Human Beta-Hexosaminidase Subunit Alpha (HEXA) Protein (Active)

Este producto es parte de HEXA - Beta-Hexosaminidase Subunit Alpha
Product Graph
1235€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Beta-Hexosaminidase Subunit Alpha (HEXA) Protein (Active)
category
Proteins and Peptides
provider
Abbexa
reference
abx691409
tested applications
SDS-PAGE

Description

Human Hexosaminidase A Protein is a recombinant protein from Human produced in Baculovirus-Insect Cells. A DNA sequence encoding the human HEXA (AAD13932.1) (Met 1-Thr 529) was fused with a polyhistidine tag at the C-terminus.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Hexosaminidase A
Host
Insect
Origin
Human
Observed MW
Molecular Weight: 59.7 kDa
Sequence Fragment: Met1-Thr529
Tag: C-terminal His tag
Validity: The validity for this protein is 12 months.
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Size 1
50 µg
Form
 
Tested Applications
SDS-PAGE
Buffer
Lyophilized from sterile 20mM Tris, 500mM NaCl, pH 7.4.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at -20°C or -80°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
NCBI Accession
AAD13932.1
Alias
N-acetyl-beta-glucosaminidase subunit alpha,TSD
Background
Protein HEXA
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

HEXA is the alpha subunit of the beta-hexosaminidase enzyme, a lysosomal hydrolase that catalyzes the breakdown of GM2 gangliosides into GM3 in the process of glycosphingolipid degradation The enzyme functions as a heterodimer composed of alpha and beta subunits, encoded by the HEXA and HEXB genes respectively Mutations in HEXA lead to Tay-Sachs disease, an autosomal recessive lysosomal storage disorder characterized by the accumulation of GM2 gangliosides in neuronal cells, resulting in neurodegeneration, progressive motor weakness, and developmental delay HEXA is highly active in neuronal tissues where glycosphingolipid metabolism is critical for normal brain function The absence or dysfunction of HEXA causes a loss of enzymatic activity leading to cellular toxicity and apoptosis Current therapeutic approaches include enzyme replacement therapy, substrate reduction therapy, and gene therapy to restore HEXA activity and slow disease progression

Related Products

abx051224

Mouse Beta-Hexosaminidase Subunit Alpha (HEXA) ELISA Kit

Mouse Beta-Hexosaminidase Subunit Alpha (HEXA) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Mouse beta hexosaminidase A concentrations in serum, plasma and other biological fluids.

Ver Producto
abx334834

Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody (FITC)

HEXA Antibody (FITC) is a Rabbit Polyclonal against HEXA.

Ver Producto
abx512150

Cow Beta-Hexosaminidase Subunit Alpha (HEXA) ELISA Kit

Cow Beta-Hexosaminidase Subunit Alpha (HEXA) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Cow Beta-hexosaminidase subunit alpha concentrations in tissue homogenates, cell lysates and other biological fluids.

Ver Producto